43 employees
Oasmia Pharmaceutical AB develops, manufactures, markets and sells an improved generation of drugs within human and veterinary oncology.
1999
$10M
from 1 investors over 1 rounds
Oasmia Pharmaceutical AB raised $10M on July 22, 2010
Investors: Yorkville Advisors